Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer

Mostrar otras versiones (1)

The optimal treatment for patients with oligometastatic non-small cell lung cancer (NSCLC) remains unclear. Some patients with oligometastatic disease can experience prolonged remission after locally consolidative radiation therapy (RT), while others harbor micrometastatic disease (below current lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Semenkovich, Nicholas P., Samson, Pamela P., Badiyan, Shahed N., Vlacich, Gregory, Stowe, Hayley B., Wang, Yun E., Star, Rachel, Devarakonda, Siddhartha, Govindan, Ramaswamy, Waqar, Saiama N., Robinson, Clifford G., Pellini, Bruna, Chaudhuri, Aadel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055612/
https://www.ncbi.nlm.nih.gov/pubmed/36993328
http://dx.doi.org/10.21203/rs.3.rs-2688927/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055612/
https://www.ncbi.nlm.nih.gov/pubmed/36993328
http://dx.doi.org/10.21203/rs.3.rs-2688927/v1

Ejemplares similares